Drugs / [6,6-2H2]glucose
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04311307 | Jan 2021 → Feb 2022 | glycogen storage disease due to glucose-6-phosphatase deficiency type IA | University Medical Center Groningen | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [6,6-2H2]glucose | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04311307 ↗ |
| Route | Oral | “two oral \[6,6-2H2\]glucose loads” NCT04311307 ↗ |